-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
Yealink Summit Addresses AI Governance and Workplace Trust
-
Essential Baking Tools for Christmas Cookie Perfection
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
NHS to test blood screening designed to detect 13 cancers earlier
-
Worcestershire road closures announced for Remembrance Sunday events
-
Democrats near House takeover as voters judge Trump presidency
-
UBC professor describes police call after Galloway remark as act of care
-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
-
Byron Donalds wins Florida governor race and underscores Republican strength
-
James Talarico defeats Ken Paxton in historic Texas Senate result
-
Physicist Claims Alberta Data Center Releases Energy of 23 Atomic Bombs Daily
-
Commentator predicts possible US strike on Iran as regional tensions rise
-
Goa plans relationship-readiness course amid concern over divorces
-
Jordan Bardella's Wealth and Financial Transparency Under Scrutiny
-
Manchester United climbs standings after 3-2 Champions League win over Roma
-
India introduces four-layer motor insurance choice from December 15
-
Mutual fund returns show shifting leaders across market-cap categories
-
DataMEDS AI Signs MOU to Deploy Health Lives Here GLP-1 Patient Management Program with Florida-Based HMO
-
Sibannac CEO Exchanges Common Shares for Series D Preferred
-
BlueFuture Aquatics, Inc. (Formerly NaturalShrimp) Announces Support for the Administration's America First Seafood Strategy
-
Glo Tanning Opens in Tempe With Red Light Therapy, Skincare and More
-
Strategic Metals Ltd. Announces Acquisition of Control and Direction of Additional Securities of GGL Resources Corp.
-
Caledonia Mining Corporation Plc: Caledonia Group Signs US$150 Million Interim Financing Facilities Agreement to Support Construction of the Bilboes Gold Project
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 05
-
How to Make the Most of a Boat Rental Vacation
-
Best Rated Gold IRA Companies 2026 for US Consumers Rankings Released by Experts
-
Clarity Tax Relief Publishes Analysis of the 2025 IRS Data Book Collection Figures
-
Ryde Signs Strategic MOU with Dimension AI to Explore US$278 Million Three-Year GPU-as-a-Service Collaboration
-
Silver Storm to Present at the 2026 Precious Metals Summit Zurich Conference
-
Euro Stablecoins Added $263 Million in a Year, Up 54%, While Dollar Supply Fell, DIA Study Finds
-
Gold Terra Announces 6.61 g/t Gold over 7.35 Metres Including 31.6 g/t Gold over 1.1 Metres on the Campbell Shear Zone 103N Extension, Con Mine, Yellowknife, NWT
-
Cognitum One Unveils MetaLLM, Self-Improving Model Control Plane for AI Agent Swarms
-
FireFox Gold Drills 6.15m at 4.10 g/t Gold at Gabbro Target, Further Expanding Gold Footprint at Mustajärvi Project, Lapland, Finland
-
Quebec Selects NiobiumX's Shipshaw Carbonatite as One of Five for Detailed Study; NiobiumX Announces Private Placement of Flow-Through Units
-
U.S. Navy Contracts with CORAS.ai to Advance Program Execution, Readiness, and Decision Intelligence
-
BHEL wins Adani Power projects valued at up to ₹28,000 crore
-
IndiGo holds talks with Embraer over potential order for 100 aircraft
-
India seeks threefold increase in coal stocks to prevent summer power shortages
-
Indian companies report mixed second-quarter results on November 4
-
Indus Towers expands solar-powered network to 50,000 telecom sites
-
KKR secures Indian regulator approval for Gentari Renewables investment
Most baby formula health claims not backed by science: study
The vast majority of health claims used to advertise baby formula worldwide are not supported by rigorous scientific evidence, a study said Thursday, leading researchers to urge the breast milk substitutes be sold in plain packaging.
The study comes a week after a group of doctors and scientists called for a regulatory crackdown on the $55-billion formula industry for "predatory" marketing which they said exploits the fears of new parents to convince them not to breastfeed.
Breastfeeding is widely recognised to have huge health benefits for babies. The World Health Organization and the US CDC recommend breastfeeding exclusively during the first six months of a newborn's life.
However that recommendation is followed for less than half of infants globally, according to the WHO.
Daniel Munblit, an honorary senior lecturer at Imperial College London and an author of the new study, said researchers were not on a "crusade" against infant formula, which should remain an option for mothers who cannot or choose not to breastfeed.
"But we are very much against inappropriate infant formula marketing, which provides misleading claims not backed up by solid evidence," Munblit told AFP.
Munblit and an international team of researchers looked at the health claims made for 608 products on the websites of infant formula companies in 15 countries, including the United States, India, Britain and Nigeria.
The most common claims were that formula supports brain development, strengthens immune systems and more broadly helps growth.
Half of the products did not link the claimed health benefit to a specific ingredient, according to the study published in the BMJ journal.
Three quarters did not refer to scientific evidence supporting their claims.
Of those that provided a scientific reference, more than half pointed to reviews, opinion pieces or research on animals.
Just 14 percent of the products referred to registered clinical trials on humans. However 90 percent of those trials carried a high risk of bias, including missing data or the finding not supporting the claim, the study said.
And nearly 90 percent of the clinical trials had authors who received funding from or had ties to the formula industry, it added.
- 'Distressing' -
The most commonly cited ingredient was polyunsaturated fatty acids, which is in breast milk and is considered important for brain development.
However there is no evidence of any added benefit when the ingredient is added to baby formula, according to a Cochrane systematic review.
Munblit said the health claims were mostly used to advertise premium formula products, which could be "distressing" for parents who are misled into believing the ingredients are essential but cannot afford them.
When asked what he thinks needs to be done to address the problem, Munblit was concise.
"Plain packaging," he said.
The study comes after a series of papers were published in the Lancet journal last week calling for global policy makers to end exploitative formula marketing.
WHO infant health specialist Nigel Rollins, an author of one of the Lancet papers, said busy parents "lack the time to properly scrutinise claims" about infant formula.
The new study showed that "governments and regulatory authorities must commit the necessary time and attention to review the claims of formula milk products," Rollins said in a linked BMJ editorial.
M.O.Allen--AT